老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akari Therapeutics PLC

1.38
-0.0200-1.43%
盘后：1.380.00000.00%19:56 EDT
成交量：8,068.00
成交额：1.10万
市值：3,984.96万
市盈率：-0.56
高：1.39
开：1.28
低：1.28
收：1.40
数据加载中...
总览公司新闻公告
2020/12/30

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/16

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/24

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/17

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/07/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/04/15

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/24

SEC问询函

[Cover]Correspondence
更多